RTOG FOUNDATION INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

QUYNH-THU LE

Phone

2157170834

Tax Period

2024-01-01 to 2024-12-31

RTOG FOUNDATION INC, founded in 2012, is a mid-sized nonprofit in the Health Care sector that reported $14.0M in total revenue in fiscal year 2024. Revenue grew 11% year-over-year, indicating healthy expansion. Expenses of $12.7M left a modest 9% surplus.

Mission

THE MISSION OF RTOG FOUNDATION, INC. (RTOGF) IS TO:(1) IMPROVE THE SURVIVAL OUTCOME AND QUALITY OF LIFE OF ADULTS WITH CANCER THROUGH THE CONDUCT OF HIGH-QUALITY CLINICAL TRIALS, (2) EVALUATE NEW FORMS OF RADIOTHERAPY DELIVERY AND TEST NEW SYSTEMIC AND TARGETED THERAPIES IN CONJUNCTION WITH RADIOTHERAPY IN THE CONTEXT OF CLINICAL RESEARCH, (3) PARTICIPATE AS ONE OF THREE MEMBER ORGANIZATIONS IN THE ACTIVITIES OF NRG ONCOLOGY FOUNDATION, (4) DEVELOP AND CONDUCT PRACTICE-CHANGING CLINICAL TRIALS FOR THE NCI NATIONAL CLINICAL TRIAL NETWORK (NCTN) THROUGH RTOGF'S MEMBERSHIP IN NRG ONCOLOGY, (5) DEVELOP AND CONDUCT INDUSTRY-SUPPORTED CLINICAL TRIALS THAT ARE IMPORTANT TO RTOGF'S RESEARCH MISSION, (6) PROVIDE FUNDING FOR BASIC, CLINICAL, AND TRANSLATIONAL INVESTIGATORS TO COLLABORATE WITH RTOGF IN THE DEVELOPMENT OF BOTH BIOLOGIC AND BIOPHYSICAL TARGETED THERAPIES, AND (7) SUPPORT YOUNG INVESTIGATORS FROM MANY DISCIPLINES WITHIN THE RTOGF RESEARCH ENTERPRISE.

Program Service Accomplishments

Program 1

Expenses: $11,805,923 Revenue: $9,403,920

RTOG'S PRIMARY PROGRAM CONSTITUTES THE FOLLOWING: (1) IMPROVE THE SURVIVAL OUTCOME AND QUALITY OF LIFE OF ADULTS WITH CANCER THROUGH THE CONDUCT OF HIGH-QUALITY CLINICAL TRIALS, (2) EVALUATE NEW...

RTOG'S PRIMARY PROGRAM CONSTITUTES THE FOLLOWING: (1) IMPROVE THE SURVIVAL OUTCOME AND QUALITY OF LIFE OF ADULTS WITH CANCER THROUGH THE CONDUCT OF HIGH-QUALITY CLINICAL TRIALS, (2) EVALUATE NEW FORMS OF RADIOTHERAPY DELIVERY AND TEST NEW SYSTEMIC AND TARGETED THERAPIES IN CONJUNCTION WITH RADIOTHERAPY IN THE CONTEXT OF CLINICAL RESEARCH, (3) PARTICIPATE AS ONE OF THREE MEMBER ORGANIZATIONS IN THE ACTIVITIES OF NRG ONCOLOGY FOUNDATION, (4) DEVELOP AND CONDUCT PRACTICE-CHANGING CLINICAL TRIALS FOR THE NCI NATIONAL CLINICAL TRIAL NETWORK (NCTN) THROUGH RTOG'S MEMBERSHIP IN NRG ONCOLOGY, (5) DEVELOP AND CONDUCT INDUSTRY-SUPPORTED CLINICAL TRIALS THAT ARE IMPORTANT TO RTOG'S RESEARCH MISSION, (6) PROVIDE FUNDING FOR BASIC, CLINICAL, AND TRANSLATIONAL INVESTIGATORS TO COLLABORATE WITH RTOG IN THE DEVELOPMENT OF BOTH BIOLOGIC AND BIOPHYSICAL TARGETED THERAPIES, AND (7) SUPPORT YOUNG INVESTIGATORS FROM MANY DISCIPLINES WITHIN THE RTOG RESEARCH ENTERPRISE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $4,176,134

Program Service Revenue $9,362,425

Investment Income $420,007

Other Revenue $41,495

TOTAL REVENUE $14,000,061

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $11,805,923

Other Expenses $12,705,224

TOTAL EXPENSES $12,705,224

Year-over-Year Comparison

	2024	2023	Change
Revenue	$14,000,061	$12,639,834	+0.1%
Expenses	$12,705,224	$11,664,696	+0.1%
Net Income	$1,294,837	$975,138	+0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DOW WILSON	DIRECTOR	1.00	Director	$0	$0	$0
GRAHAM BURNETTE ESQ	DIRECTOR	1.00	Director	$0	$0	$0
JEFF MICHALSKI MD MBA	TREASURER	1.00	Officer Director	$0	$0	$0
JIM DIGNAM PHD	DIRECTOR	1.00	Director	$0	$0	$0
KRISTIN HIGGINS MD	DIRECTOR	1.00	Director	$0	$0	$0
LISA KACHNIC MD	DIRECTOR	1.00	Director	$0	$0	$0
MITCHELL MACHTAY MD	PRESIDENT & CEO	5.00	Officer Director	$0	$0	$0
QUYNH LE MD	CHAIR	5.00	Officer Director	$0	$0	$0
SETH ROSENTHAL MD	DIRECTOR	1.00	Director	$0	$0	$0
STUART WONG MD	SECRETARY	1.00	Officer Director	$0	$0	$0
SUE YOM MD	DIRECTOR	1.00	Director	$0	$0	$0
WALTER J CURRAN JR MD	DIRECTOR	1.00	Director	$0	$0	$0
MARK MISHRA MD	DIRECTOR	1.00	Director	$0	$0	$0
EDWIN POSADAS MD	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$14,000,061	$12,705,224	$20,327,245	$1,294,837
2023	$12,639,834	$11,664,696	$16,896,589	$975,138
2022	$11,934,766	$10,428,486	$15,118,673	$1,506,280
2021	$6,561,535	$7,885,522	$10,342,373	$-1,323,987
2020	$7,861,321	$8,206,629	$2,206,431	$-345,308
2019	$6,954,872	$8,588,379	$2,877,464	$-1,633,507
2018	$9,645,069	$9,286,665	$4,229,460	$358,404